Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
10 March 2020 | Story Rulanzen Martin | Photo Victor Sguassero (kykNET)
Chris Vorster
Chris was on stage in 'Die Hart Verklap' at the Toyota US Woordfees in Stellenbosch recently.

“Difficult and very strange,” is how Chris Vorster, veteran actor and Drama lecturer at the University of the Free State (UFS) describes his role as Bas Koorts in the supernatural thriller Die Spreeus

For Chris, the biggest challenge during the filming of Die Spreeus was to work in front of a green screen. “You never see the monsters and things attacking you, it is only added later on during the editing process,” he said. Therefore, he and his co-actors were expected to use their own imagination “to be frightened, and to duck and dive from something that does not exist.” 

This Afrikaans thriller series has recently been nominated in five categories of the South African Film and Television Awards, including Best Television Drama, Best Cinematography, and Original Sound and Sound Editing. 

Chris was also nominated for a Fiësta award in 2019 for his one-man performance in the theatre production, Die Hart verklap. “It is fantastic to still be recognised for my work,” he said, “but I also have to give recognition to Dion van Niekerk, because without a good director, any actor will be lost.” Van Niekerk also lectures Drama at the UFS.

Being a lecturer broadens his knowledge 

Chris joined the UFS Department of Drama and Theatre Arts in 2015 as lecturer in the programme for Film en Visual Media. “Everything I learn in the industry I apply as lecturer, and research and teaching feed more knowledge on acting, directing, and especially writing,” he said. After five years, being involved with the UFS Department of Drama is still exciting to him. “This is where both lecturers and students get encouraged to do more than just breathing.” 

With his busy schedule of teaching and acting, it remains important to him that South Africans are still able to tell stories – “in any language”. He considers it a privilege for anyone to work in their mother tongue. This is also why the symbiosis between his work as actor and lecturer is so appealing.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept